Bioequivalence Study of Cyclobenzaprine Hydrochloride 10 mg Tablets, USP Under Fasting Conditions
Status:
Completed
Trial end date:
2006-11-01
Target enrollment:
Participant gender:
Summary
To compare the single-dose oral bioavailability of Cyclobenzaprine hydrochloride 10 mg tablet
of Ohm Labs Inc (A subsidiary of Ranbaxy Pharmaceuticals Inc USA.) with Flexeril® 10 mg
tablet (containing Cyclobenzaprine hydrochloride 10 mg) of McNeil Consumer & Specialty
Pharmaceuticals, in healthy, adult, male, human subjects under fasting condition.